Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2016 May 7:17:13-5.
doi: 10.1016/j.gore.2016.05.001. eCollection 2016 Aug.

Correction of coagulopathy associated with non-bacterial thrombotic endocarditis (NBTE) by surgical debulking in a case of ovarian clear cell carcinoma

Benjamin B Albright  1 , Jonathan D Black  2 , Nicole Vilardo  2 , Peter E Schwartz  2
Affiliations
Case Reports

Correction of coagulopathy associated with non-bacterial thrombotic endocarditis (NBTE) by surgical debulking in a case of ovarian clear cell carcinoma

Benjamin B Albright et al. Gynecol Oncol Rep. .

Abstract

•Ovarian cancer, particularly clear cell carcinoma, creates a hypercoagulable state.•This state can predispose to non-bacterial thrombotic endocarditis (NBTE).•NBTE can embolize and cause widespread arterial infarction.•NBTE is sometimes associated with a treatment refractory disseminated coagulopathy.•Surgical removal of the primary mass can sometimes reverse the coagulopathy.

Keywords: Hypercoaguability of malignancy; Non-bacterial thrombotic endocarditis; Ovarian clear cell carcinoma.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Abu Saadeh F., Norris L., O'Toole S., Gleeson N. Venous thromboembolism in ovarian cancer: incidence, risk factors and impact on survival. Eur. J. Obstet. Gynecol. Reprod. Biol. 2013 Sep;170(1):214–218. - PubMed
    1. Levitan N., Dowlati A., Remick S.C., Tahsildar H.I., Sivinski L.D., Beyth R. Rates of initial and recurrent thromboembolic disease among patients with malignancy versus those without malignancy. Risk analysis using Medicare claims data. Medicine. 1999 Sep;78(5):285–291. - PubMed
    1. Baron J.A., Gridley G., Weiderpass E., Nyrén O., Linet M. Venous thromboembolism and cancer. Lancet. 1998 Apr 11;351(9109):1077–1080. - PubMed
    1. Falanga A., Anna F., Laura R., Cristina V. Mechanisms of thrombosis in cancer. Thromb. Res. 2013;131:S59–S62. - PubMed
    1. el-Shami K., Griffiths E., M. Streiff. Nonbacterial thrombotic endocarditis in cancer patients: pathogenesis, diagnosis, and treatment. Oncologist. 2007 May;12(5):518–523. - PubMed

Publication types

LinkOut - more resources